insights_auto
Why is ARGX down 2.08%?
Dive Deeperchevron_right
ARGX:NASDAQ
argenx SE - ADR
$916.49
arrow_downward
-2.08%(-19.51) 1D
Oct 2, 2:43:09 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$926.86
High
$928.96
Low
$912.96
Mkt. cap
58.40B
Avg. vol.
255.29K
Volume
254.92K
P/E ratio
34.82
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.56M
No. of employees
2K
Open
$926.86
High
$928.96
Low
$912.96
Mkt. cap
58.40B
Avg. vol.
255.29K
Volume
254.92K
P/E ratio
34.82
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
Argenx stock after-hours at EUR 815.70: minus 2.59 percent versus prior close
AD HOC NEWS
·
7 hours ago
Goldman Sachs raises target for Argenx stock from EUR 973 to EUR 982
AD HOC NEWS
·
3 days ago
argenx stock after-hours at EUR 850.90: minus 0.58 percent versus prior close
TipRanks
·
3 days ago
Argenx Unveils New VYVGART and Pipeline Data at AANEM and MGFA
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR